Android app Apple app link

Enliven Therapeutics, Inc. (ELVN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$27.81
Day's range
$30.3

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/02/2026 Morgan Stanley Sean Laaman $70.00 $46.21   51.48%
08/18/2026 Mizuho Securities Salim Syed $73.00 $59.54   22.62%
08/18/2026 Barclays Etzer Darout $78.00 $59.54   31.02%
08/06/2026 Stifel Nicolaus Dara Azar $82.00 $60.68   35.15%
08/06/2026 Guggenheim Michael Schmidt $78.00 $59.70   30.65%
07/21/2026 Goldman Sachs Salveen Richter $67.00 $51.67   29.67%
07/09/2026 H.C. Wainwright Robert Burns $65.00 $50.80   27.95%
06/02/2026 Mizuho Securities Salim Syed $62.00 $37.51   65.29%
06/16/2025 Robert W. Baird Colleen Kusy $52.00 $23.09   125.21%
11/15/2024 Robert W. Baird Colleen Kusy $40.00 $24.05   66.32%
09/23/2024 Mizuho Securities Salim Syed $39.00 $23.80   63.87%
06/10/2024 Robert W. Baird Colleen Kusy $32.00 $22.58   41.72%
04/09/2024 Mizuho Securities Salim Syed $34.00 $18.30   85.79%

Enliven Therapeutics Inc FAQ's

Enliven Therapeutics Inc has been rated by research analysts at Morgan Stanley, Mizuho Securities, Barclays, Stifel Nicolaus, Guggenheim, Goldman Sachs in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.